Company Search:
Advanced Search
Sponsored Links
Oasmia Pharmaceutical AB Company Snapshot
Oasmia Pharmaceutical AB operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Oasmia Pharmaceutical AB with three other pharmaceutical manufacturers in Europe: Infant Bacterial Therapeutics AB (2017 sales of 238,000.00 Swedish Kronor [US$27,165.32 ] ), Irlab Therapeutics Ab (109,000.00 Swedish Kronor [US$12,441.26 ] ), and NUTEX Investments Plc which is based in Hungary (8.76 million Hungarian Forints [US$32,149.20 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Oasmia Pharmaceutical AB
  Stock Performance Chart for Oasmia Pharmaceutical AB
  Stock Data: Recent Stock Performance:
  Current Price (5/25/2018): 4.11
(Figures in Swedish Kronor)
1 Week -4.6%   13 Weeks -16.5%  
4 Weeks 5.7%   52 Weeks -21.5%  
Oasmia Pharmaceutical AB Key Data:
  Ticker: OASM Country: Sweden
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 172,000
(Year Ending Jan 2018).
Employees: 75
  Currency: Swedish Kronor Market Cap: 725,028,660
  Fiscal Yr Ends: April Shares Outstanding: 176,406,000
  Share Type: Closely Held Shares: 73,486,204
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.